PROLIFERATION AND DIFFERENTIATION OF HUMAN CD5+ AND CD5- B-CELL SUBSETS ACTIVATED THROUGH THEIR ANTIGEN RECEPTORS OR CD40-ANTIGENS

被引:56
作者
DEFRANCE, T
VANBERVLIET, B
DURAND, I
BRIOLAY, J
BANCHEREAU, J
机构
[1] Schering-Plough, Laboratory for Immunological Research, Dardilly
关键词
D O I
10.1002/eji.1830221112
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pan-T cell antigen CD5 has been shown to delineate two different mouse B cell subsets, originating from distinct progenitors. In man, on average. 30% of the tonsillar B cell pool expresses this antigen. In the present report, a detailed comparison of the CD5+ and CD5- B cell response to cytokines, following activation via surface immunoglobulins (sIg) or CD40 antigen, was undertaken. CD5+ B cells were positively selected by panning or by sorting from tonsils. Two-color immunofluorescence analysis performed on tonsillar B cell populations showed that CD5+ B cells displayed most of the phenotypic features of mantle zone B cells. CD5+ B cells could be stimulated for DNA synthesis by mitogenic concentrations of Staphylococcus aureus, Cowan I strain (SAC), insolubilized anti-IgM antibodies, immobilized anti-CD40 antibodies and phorbol 12-myristate 13-acetate (PMA). The growth-response of small dense CD5- B cells to these T cell-independent mitogens was comparable to that of CD5+ B cells, whereas the low-density, in vivo-activated, CD5- B cells were only marginally stimulated by Ig-cross-linking agents and PMA. Following ligation of sIg, both B cell subsets proliferated essentially in response to interleukin (IL)-2 and IL-4. When used in co-stimulation with immobilized anti-CD40 antibodies, IL-4 promoted growth of CD5+ and CD5- B cells, whereas IL-2 displayed only moderate stimulatory effects. CD5+ and CD5- B cells differentiated into Ig-secreting cells when they were co-cultured with SAC or cross-linked anti-CD40 antibodies and IL-2. However, IgM constituted the major component of the Ig response of CD5+ B cells, whereas high levels of IgG were secreted by CD5- B cells.
引用
收藏
页码:2831 / 2839
页数:9
相关论文
共 43 条
[31]  
SAELAND S, 1991, BLOOD, V78, P2229
[32]  
SMITHRAVIN J, 1990, CLIN EXP IMMUNOL, V82, P181
[33]   ANTI-DNA ANTIBODY-PRODUCTION BY CD5+ AND CD5- B-CELLS OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
SUZUKI, N ;
SAKANE, T ;
ENGLEMAN, EG .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (01) :238-247
[34]  
TOUW I, 1987, BLOOD, V69, P1667
[35]  
UMLAND SP, 1989, J IMMUNOL, V142, P1528
[36]   ACTIVATION OF HUMAN LYMPHOCYTES-B THROUGH CD40 AND INTERLEUKIN-4 [J].
VALLE, A ;
ZUBER, CE ;
DEFRANCE, T ;
DJOSSOU, O ;
DERIE, M ;
BANCHEREAU, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (08) :1463-1467
[37]  
VAN DE VELDE H, 1991, NATURE, V351, P662
[38]   INVIVO EXPRESSION OF INTERLEUKIN-5 INDUCES AN EOSINOPHILIA AND EXPANDED LY-1B LINEAGE POPULATIONS [J].
VAUX, DL ;
LALOR, PA ;
CORY, S ;
JOHNSON, GR .
INTERNATIONAL IMMUNOLOGY, 1990, 2 (10) :965-971
[39]   IDENTIFICATION OF A P69,71 COMPLEX EXPRESSED ON HUMAN T-CELLS SHARING DETERMINANTS WITH B-TYPE CHRONIC LYMPHATIC LEUKEMIC-CELLS [J].
WANG, CY ;
GOOD, RA ;
AMMIRATI, P ;
DYMBORT, G ;
EVANS, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 151 (06) :1539-1544
[40]   CELL-SURFACE ANTIGEN CD5 IS A MARKER FOR ACTIVATED HUMAN B-CELLS [J].
WERNERFAVRE, C ;
VISCHER, TL ;
WOHLWEND, D ;
ZUBLER, RH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (07) :1209-1213